Pharmaceutical doesn't blame tort system for high prices
And not greedy trial lawyers, surprisingly.
“The psychology of the industry is that, if you are first, the price should be high,” [Elan CEO] Martin tells The Financial Times. “The economic structure is unsustainable. The tension will grow and something has to give.”
Of course if you're first to market, your prices are going to be high. It's just refreshing to read a CEO admit that openly and not claim it's because of the tort system.